Clinical trial
Safety and Clinical Effectiveness of A3 SVF in Osteoarthritis
NCT01947348 is registered in ClinicalTrials.gov with Institute of Regenerative and Cellular Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Clinical Effectiveness of A3 SVF in Osteoarthritis
- Lead sponsor
- Institute of Regenerative and Cellular Medicine
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 30, 2012
- Completion date
- September 30, 2015
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.